Skip to main content
OpenTrials

Clinical trial condition

Hemophilia A

Explore clinical trials studying Hemophilia A. Study availability and eligibility vary by location and protocol.

600 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia A trial results

Completed

A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)

NCT03741881

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +12 more
Locations
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Sacramento, California, United States
  • Novo Nordisk Investigational Site Aurora, Colorado, United States
  • Novo Nordisk Investigational Site Washington D.C., District of Columbia, United States
View all 143 locations
View Trial Details
Completed

A Trial Evaluating Efficacy and Safety of Prophylactic Administration of Concizumab in Patients With Severe Haemophilia A Without Inhibitors

NCT03196297

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Indianapolis, Indiana, United States
  • Novo Nordisk Investigational Site Oklahoma City, Oklahoma, United States
  • Novo Nordisk Investigational Site Nashville, Tennessee, United States
View all 31 locations
View Trial Details
Completed

A Study of Zidovudine in HIV-Infected Patients Who Have Hemophilia

NCT00001104

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Behavior, +25 more
Locations
  • Los Angeles County - USC Med Ctr Los Angeles, California, United States
  • Univ of California / San Diego Treatment Ctr San Diego, California, United States
  • Stanford Univ School of Medicine Stanford, California, United States
  • Northwestern Univ Med School Chicago, Illinois, United States
View all 23 locations
View Trial Details
Completed

An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A

NCT02172950

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Study Site 8400213 San Diego, California, United States
  • Study Site 8400241 Aurora, Colorado, United States
  • Study Site 8400118 Hartford, Connecticut, United States
  • Study Site 8400116 Miami, Florida, United States
View all 64 locations
View Trial Details

Related conditions